Monitor for subsequent Form 4 filings for any open-market purchases or grants of restricted stock/options, which would signal conviction in the new CMO's conviction. The zero-ownership baseline provides a clean baseline for tracking future insider activity.
Price Chart
Executive Summary
Noah Berkowitz filed a Form 3 initial statement of beneficial ownership after joining Iovance Biotherapeutics as Chief Medical Officer on September 30, 2026. The filing is a routine insider onboarding disclosure with no financial figures or trading activity reported.
Key Facts
- Noah Berkowitz appointed Chief Medical Officer effective September 30, 2026
- Form 3 filed October 2, 2026, initial ownership statement
- No securities ownership reported (all fields zero)
- Business address: C/O Iovance Biotherapeutics, 300 Rouse Blvd., Philadelphia, PA
Financial Impact
No financial impact, routine insider onboarding filing with zero reported ownership
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001104659-26-113341 |
| Document: 0001104659-26-113341-index.html | 0001104659-26-113341 |
| Document: 0001104659-26-113341.txt | 0001104659-26-113341 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 29, 2026 today | 8-K | $9.35 | awaiting T+20 | awaiting T+20 | $14.81 (+58.40%) |
Oct 28, 2026 1d ago | Press Release | $15.39 | awaiting T+20 | awaiting T+20 | $14.81 (−3.79%) |
Oct 5, 2026 24d ago | 8-K | $12.96 | awaiting T+20 | awaiting T+20 | $14.81 (+14.27%) |
Oct 2, 2026 27d ago | 3 | $14.15 | awaiting T+20 | awaiting T+20 | $14.81 (+4.66%) |
Sep 29, 2026 4w ago | 8-K | $14.45 $14.58 | ▲ +0.90% | ▲ +0.19% | $14.81 (+2.49%) |
Aug 21, 2026 9w ago | Press Release | $8.06 $10.64 | ▲ +32.01% | ▲ +30.70% | $14.81 (+83.75%) |
Aug 6, 2026 12w ago | 8-K | $6.34 $8.79 | ▲ +38.64% | ▲ +39.04% | $14.81 (+133.60%) |
Aug 6, 2026 12w ago | 8-K | $6.21 $8.70 | ▲ +40.10% | ▲ +39.50% | $14.81 (+138.49%) |
Jul 16, 2026 15w ago | Court Ruling | $5.00 $6.98 | ▼ −39.60% | ▼ −35.15% | $14.81 (−196.20%) |
Jul 2, 2026 17w ago | 8-K | $4.31 $4.69 | ▲ +8.82% | ▲ +9.23% | $14.81 (+243.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers